UroGen Pharma Ltd.URGNNASDAQ
LOADING
|||
Revenue Growth Under Pressure
Below historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
0.00%
↓ 100% below average
Average (39q)
12.49%
Historical baseline
Range
High:830.38%
Low:-100.00%
Volatility
7450.1%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 0.00% |
| Q2 2025 | -100.00% |
| Q1 2025 | -17.55% |
| Q4 2024 | -2.54% |
| Q3 2024 | 15.36% |
| Q2 2024 | 16.33% |
| Q1 2024 | -20.18% |
| Q4 2023 | 12.84% |
| Q3 2023 | -1.36% |
| Q2 2023 | 22.96% |
| Q1 2023 | -4.97% |
| Q4 2022 | 12.39% |
| Q3 2022 | -3.05% |
| Q2 2022 | 22.41% |
| Q1 2022 | -16.14% |
| Q4 2021 | 42.49% |
| Q3 2021 | -12.90% |
| Q2 2021 | 74.11% |
| Q1 2021 | -6.04% |
| Q4 2020 | 130.16% |
| Q3 2020 | 830.38% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | -100.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | -100.00% |
| Q3 2018 | -22.25% |
| Q2 2018 | -24.32% |
| Q1 2018 | 47.09% |
| Q4 2017 | -95.81% |
| Q3 2017 | 0.00% |
| Q2 2017 | -100.00% |
| Q1 2017 | -99.89% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |
| Q4 2015 | 0.00% |